Related Experiment Videos
Biatrial primary synovial sarcoma of the heart
Qiong Zhao1, Alexander S Geha, Stephen R Devries
1Section of Cardiology, Department of Medicine, The University of Illinois at Chicago School of Medicine, Chicago, Illinois 60612, USA. qiongzhao@yahoo.com
Insights
Primary biatrial synovial sarcoma is a rare heart cancer. This aggressive tumor, often affecting young males, has a poor prognosis and requires multimodal treatment including surgery and chemotherapy.
Area of Science:
- Cardiovascular Pathology
- Oncology
- Molecular Diagnostics
Background:
- Synovial sarcoma primarily originating in the heart and pericardium is exceptionally rare, particularly when affecting both atria.
- Few documented cases exist, highlighting the rarity and diagnostic challenges of this condition.
Observation:
- A 36-year-old male presented with a primary biatrial synovial sarcoma involving the tricuspid annulus, heart valves, and interatrial septum.
- Tumor debulking was performed to alleviate atrioventricular obstruction.
- Molecular analysis confirmed synovial sarcoma with the characteristic t(X;18) SYT-SSX gene fusion.
Findings:
- Review of 20 reported cases indicates a predilection for young male patients.
- The condition carries a poor prognosis, with early detection being difficult due to its aggressive nature.
- The t(X;18) SYT-SSX gene fusion is a key diagnostic marker.
Implications:
- Wide surgical resection is the primary therapeutic approach for localized disease.
- Adjuvant radiation therapy and chemotherapy may offer limited benefits for local recurrence and systemic disease control, respectively.
- Further research is needed to improve outcomes for this rare and aggressive cardiac malignancy.
Abstract:
Synovial sarcomas that primarily arise from the heart and pericardium are extremely rare, especially the ones involving both sides of the heart. To date, few cases have been reviewed in the literature. Our patient was a 36-year-old man who presented with primary biatrial synovial sarcoma that also involved the tricuspid annulus, heart valves, and interatrial septum. The tumor was debulked to relieve the atrioventricular obstruction. Molecular analysis confirmed the diagnosis of synovial sarcoma with positive t (X;18) SYT-SSX gene fusion. The patient is currently receiving chemotherapy. From our review of the 20 cases thus far reported in the English-language medical literature, the tumor more frequently affects young male patients, and carries a poor prognosis. Early detection is difficult because of the aggressive nature of the tumor. Like other sarcomas, wide surgical resection remains the mainstay of therapy. Adjuvant radiation therapy for local recurrence and chemotherapy for control of systemic disease may have some beneficial effect on overall survival, but the benefit is likely limited.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Pericarditis I: Introduction
Rheumatic Heart Disease I: Introduction
Myocarditis I: Introduction
Cardiomyopathy II: Dilated Cardiomyopathy